What are the adverse effects of intravenous vitamin B12 (cobalamin)?

Adverse Effects of Intravenous Vitamin B12

Intravenous vitamin B12 can cause serious adverse effects including anaphylactic shock and death, though these reactions are rare; other documented adverse effects include cardiovascular complications (pulmonary edema, congestive heart failure, peripheral vascular thrombosis), polycythemia vera, and dermatological reactions. 1

Serious and Life-Threatening Reactions

The FDA drug label explicitly warns that anaphylactic shock and death have been reported with parenteral vitamin B12 administration. 1 These hypersensitivity reactions, while uncommon, represent the most critical safety concern with IV administration. 2, 3

• Allergic reactions appear more likely with parenteral (IV or IM) routes compared to oral administration 2, 4
• Long-term administration of cobalamin may predispose patients to developing allergy to vitamin B12, regardless of chemical form 4
• When anaphylactic reactions occur, patients typically tolerate oral vitamin B12 as an alternative, though very high doses (1,000-2,000 mcg daily) are necessary due to malabsorption 2

Cardiovascular Adverse Effects

Early in treatment, IV vitamin B12 can precipitate cardiovascular complications including:

• Pulmonary edema and congestive heart failure 1
• Peripheral vascular thrombosis 1

These cardiovascular effects are particularly concerning in the initial treatment phase and require clinical vigilance.

Hematological Effects

• Polycythemia vera has been reported as an adverse effect of parenteral vitamin B12 1

Other Common Adverse Effects

Dermatological reactions:

• Itching 1
• Transitory exanthema (rash) 1

Gastrointestinal effects:

• Mild transient diarrhea 1

Systemic reactions:

• Feeling of swelling of entire body 1

Clinical Implications and Management

Intravenous administration results in rapid excretion with little opportunity for liver storage, with 50-98% of an injected dose appearing in urine within 48 hours, and the major portion excreted within the first 8 hours. 1 This rapid excretion profile with IV administration is even more pronounced than with intramuscular injection. 1

Desensitization Option

For patients who develop hypersensitivity but require continued vitamin B12 supplementation, desensitization protocols using cyanocobalamin appear effective in obtaining tolerance, allowing for long-term supplementation regardless of chemical form, dose, frequency, or route of administration. 4 Various protocols exist differing in duration, dose escalation dynamics, and injection method (IM vs subcutaneous). 4

Important Caveats

• The reaction may be to the vitamin B12 molecule itself or represent an IgE-mediated reaction 3
• Hypersensitivity should be kept in mind especially with parenteral administration 3
• Recent evidence from septic shock trials using high-dose IV hydroxocobalamin (5g single dose) showed no serious adverse events, suggesting safety even at very high doses in critically ill patients 5